期刊文献+

剔除子宫腺肌瘤同时宫腔内置入曼月乐的术后疗效评估 被引量:1

Effect of removal of endometriomas combined with mirena placed in uterine cavity
下载PDF
导出
摘要 目的:探讨剔除子宫腺肌瘤同时宫腔内置入曼月乐对术后疗效的评估。方法:收治子宫腺肌瘤患者84例,随机分为对照组与研究组,对照组采用肌瘤剔除术治疗,研究组在对照组基础上宫腔内置入曼月乐,比较两组治疗效果。结果:治疗12个月后,研究组的痛经VAS评分显著低于对照组(P<0.05);随访结果显示,研究组的月经量明显减少,子宫体积明显缩小(P<0.05)。结论:剔除子宫腺肌瘤同时宫腔内置入曼月乐可有效缓解痛经与月经量多的情况,并能缩小子宫体积。 Objective:To explore the effect of removal of endometriomas combined with mirena placed in uterine cavity.Methods:84 patients with uterine adenomyoma were selected.They were randomly divided into the control group and the study group.The control group was treated with myomectomy.The study group was treated with mirena placed in uterine cavity on the basis of the control group.We compared the therapeutic effect of two groups.Results:After 12 months of treatment,the dysmenorrhea VAS score of the study group was significantly lower than that of the control group(P<0.05).The follow-up results showed that the amount of menstruation was significantly decreased in the study group,and the uterine volume was significantly reduced(P<0.05).Conclusion:Removal of endometriomas combined with mirena placed in uterine cavity can effectively alleviate the situation of dysmenorrhea and menorrhagia,and can reduce the volume of the uterus.
作者 李馨蕊 王静 姜海英 Li Xinrui;Wang Jing;Jiang Haiying(Obstetrics and Gynecology Department,the General Hospital of Jilin Chemical Group Company 132021)
出处 《中国社区医师》 2016年第25期76-77,共2页 Chinese Community Doctors
关键词 曼月乐 子宫腺肌瘤剔除术 疗效 Mirena Removal of endometriomas Curative effect
  • 相关文献

参考文献4

二级参考文献39

  • 1李亚里,姚元庆.妇产科聚焦[M].北京:人民军医出版社, 2011:147-148,153-154.
  • 2洪颖,胡志沁,黄志勇,罗宁玲.子宫腺肌病的激素受体免疫组织化学分析[J].中国实用妇科与产科杂志,1997,13(3):158-158. 被引量:12
  • 3Kelekci S,Kelekci KH,Yilmaz B. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis[J].Contraception,2012,(05):458-463.
  • 4Lindh I,Milsom I. The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea:a longitudinal population study[J].Human Reproduction,2013,(07):1953-1960.
  • 5Bednarek PH,Jensen JT. Safety,efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS[J].International Journal of Women's Health,2010,(02):145-158.
  • 6Vieira da Motta M,Vieira da Motta E. Levonorgestrel-releasing intrauterine system and iron overload syndrome[J].Clinical Medicine Insights: Case Reports,2013,(02):693-697.
  • 7Dolapcioglu K,Boz A,Baloglu A. The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia.A prospective randomized comparative study[J].Clinical and Experimental Obstetrics and Gynecology,2013,(01):122-126.
  • 8Petta CA,Ferriani RA,Abrao MS,et al.Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis[J].Hum Reprod,2005,20(7):1993-1998.
  • 9Liu L,Li Y,Xu H,et al.Laparoscopic transient uterine artery occlusion and myomectomy for symptomatic uterine myoma[J].Fertil Steril,2011,95(1):254-258.
  • 10Murphy AA,Kettel LM,Morales AJ,et al.Regression of Uterine leiomyomata in response to the antiprogesterone RU486[J].J Clin Endocrinol Metab,1993,76(2):513-517.

共引文献74

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部